Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Zimarino

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Giornale Italiano Di Cardiologia (2006)|September 24, 2010
[Vulnerable plaque imaging: is it time for its application in clinical practice?]Francesco Prati, Marco Zimarino
International Journal of Cardiology|August 29, 2021
Intravascular ultrasound for in-stent restenosis: A problem well stated is half-solvedFederico Archilletti, Marco Zimarino
Cardiology Journal|January 5, 2022
Are we ready to withdraw acetylsalicylic acid after complex percutaneous coronary intervention?Gabriella Bufano, Marco Zimarino
International Journal of Cardiology|September 18, 2025
Coronary calcifications are the growth rings of coronary atherosclerotic plaqueMichele Russo, Marco Zimarino
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 21, 2012
The prognosis of periprocedural myocardial infarction after percutaneous coronary interventionsMarco Zimarino, Vincenzo Affinito
Giornale Italiano Di Cardiologia (2006)|April 23, 2010
[The TIMACS study]Giuseppe Steffenino, Marco Zimarino
The New England Journal of Medicine|April 15, 2011
A natural-history study of coronary diseaseMarco Zimarino, Raffaele De Caterina
Journal of Cardiovascular Pharmacology|April 13, 2004
Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: part 1: the evidence of benefitMarco Zimarino, Raffaele De Caterina
Giornale Italiano Di Cardiologia (2006)|February 26, 2011
[The optimal time window for percutaneous coronary intervention in thrombolysis-treated ST-elevation myocardial infarction]Raffaele De Caterina, Marco Zimarino
Journal of Cardiovascular Pharmacology|April 16, 2004
Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: Part 2: When and how to use various agentsMarco Zimarino, Raffaele De Caterina
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Giornale Italiano Di Cardiologia (2006)|September 24, 2010
[Vulnerable plaque imaging: is it time for its application in clinical practice?]Francesco Prati, Marco Zimarino
International Journal of Cardiology|August 29, 2021
Intravascular ultrasound for in-stent restenosis: A problem well stated is half-solvedFederico Archilletti, Marco Zimarino
Cardiology Journal|January 5, 2022
Are we ready to withdraw acetylsalicylic acid after complex percutaneous coronary intervention?Gabriella Bufano, Marco Zimarino
International Journal of Cardiology|September 18, 2025
Coronary calcifications are the growth rings of coronary atherosclerotic plaqueMichele Russo, Marco Zimarino
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 21, 2012
The prognosis of periprocedural myocardial infarction after percutaneous coronary interventionsMarco Zimarino, Vincenzo Affinito
Giornale Italiano Di Cardiologia (2006)|April 23, 2010
[The TIMACS study]Giuseppe Steffenino, Marco Zimarino
The New England Journal of Medicine|April 15, 2011
A natural-history study of coronary diseaseMarco Zimarino, Raffaele De Caterina
Journal of Cardiovascular Pharmacology|April 13, 2004
Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: part 1: the evidence of benefitMarco Zimarino, Raffaele De Caterina
Giornale Italiano Di Cardiologia (2006)|February 26, 2011
[The optimal time window for percutaneous coronary intervention in thrombolysis-treated ST-elevation myocardial infarction]Raffaele De Caterina, Marco Zimarino
Journal of Cardiovascular Pharmacology|April 16, 2004
Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: Part 2: When and how to use various agentsMarco Zimarino, Raffaele De Caterina
Pageof 18